The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties Qiyu QiuFabienne DudouitBertrand J. Jean-Claude Original Article Pages: 1 - 10
Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41 Stephanie L. MathesonJames P. McNameeBertrand J. Jean-Claude Original Article Pages: 11 - 20
Evidence for the involvement of ETB receptors in ET-1-induced changes in blood flow to the rat breast tumor Aarati RaiAnil Gulati Original Article Pages: 21 - 28
Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer Yasuhiro HiranoShinji KageyamaKimio Fujita Original Article Pages: 29 - 35
Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig Andreas EkbornAnnika LindbergHans Ehrsson Original Article Pages: 36 - 42
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) Bronwyn G. SiimAlan E. LeeWilliam R. Wilson Original Article Pages: 43 - 52
Delivery of interleukin-12 in gelatin hydrogels effectively suppresses development of transplanted colonal carcinoma in mice Lili LiuTakeo SakaguchiKatsuyoshi Hatakeyama Original Article Pages: 53 - 57
A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005) Anne O'DonnellCornelis J. PuntPhilip Beale Original Article Pages: 58 - 66
Biological properties of jatrophane polyesters, new microtubule-interacting agents Antonella MigliettaLudovica GabrielClaudia Bocca Original Article Pages: 67 - 74
Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats Rutao CuiJinchun HeHong Shen Original Article Pages: 75 - 80
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia Yesid AlvaradoJorge CortesFrancis J. Giles Short Communication Pages: 81 - 86
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia Yesid AlvaradoApostolia TsimberidouFrancis J. Giles Short Communication Pages: 87 - 90
Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function Jocelyn CéralineGaël DeplanqueClaudine Klein-Soyer Short Communication Pages: 91 - 95
